Clincosm LogoSign in Get a demo

Dry Eye Syndromes

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndromes, Dry Eye Trial in United States (RGN-259, Placebo)

Completed
  • Dry Eye Syndromes
  • Dry Eye
  • Phoenix, Arizona
  • +19 more
May 2, 2022

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • KPI-121 0.25% Ophthalmic Suspension
  • Vehicle of KPI-121 0.25% Ophthalmic Suspension
  • Birmingham, Alabama
  • +61 more
Dec 10, 2020

Dry Eye Syndromes Trial in Louisville, Memphis, Nashville (Intranasal Tear Neurostimulator)

Completed
Has Results
  • Dry Eye Syndromes
  • Intranasal Tear Neurostimulator
  • Louisville, Kentucky
  • +2 more
Jan 17, 2020

Dry Eye Syndromes Trial in United States (SJP-0035 0.001%, Placebo)

Completed
  • Dry Eye Syndromes
  • SJP-0035 0.001%
  • Placebo
  • Chandler, Arizona
  • +22 more
Apr 13, 2019

Dry Eye Syndromes Trial in United States (AGN-195263, Vehicle)

Terminated
Has Results
  • Dry Eye Syndromes
  • Chandler, Arizona
  • +28 more
Feb 15, 2019

Validation of TearLab Osmometer - Human Factor Usability Report

Completed
Has Results
  • Dry Eye Syndromes
    • San Diego, California
    • +2 more
    Mar 14, 2016

    Dry Eye Syndromes Trial in United States (CP-690,550, Cyclosporine, CP-690,550 Vehicle)

    Completed
    Has Results
    • Dry Eye Syndromes
    • Chandler, Arizona
    • +26 more
    Feb 27, 2013

    Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (rebamipide 2% ophthalmic suspension, eye drops)

    Completed
    • Dry Eye Syndromes
    • Keratoconjunctivitis Sicca
    • rebamipide 2% ophthalmic suspension
    • placebo eye drops
    • Waterbury, Connecticut
    • +4 more
    Jan 9, 2012